Leroy K, Farrell R, Kerner C: Polyethylene Glycol Allergy Implicated in Lubricant Intolerance Poster Presentation/American College of Gastroenterology Annual Meeting : 2017.
Farrell R, Leroy K, Kerner C: Acute Symptomatic Hyponatremia Associated With Polyethylene Glycol Bowel Preparation Poster Presentation/American College of Gastroenterology Annual Meeting : 2017.
Kerner Caroline: Commentary on Variations in Health Insurance Policies Regarding Biological Therapy Use in IBD and a Modified Delphi Process for the Development of Choosing Wisely for IBD. Inflammatory bowel diseases 23 (6): 866-867,2017.
Carr Rotonya M, Patel Arpan, Bownik Hillary, Oranu Amanke, Kerner Caroline, Praestgaard Amy, Forde Kimberly A, Reddy K Rajender, Lichtenstein Gary R: Intestinal Inflammation Does Not Predict Nonalcoholic Fatty Liver Disease Severity in Inflammatory Bowel Disease Patients. Digestive diseases and sciences 62 (5): 1354-1361,2017.
Buchner AM, Gene M, Kener C, Ginsberg GG, Lichtenstein GR: Chromoendoscopy-guided probe based confocal laser endomicroscopy: A novel approach for dysplasia evaluation in IBD surveillance Gastroenterology (Supplement) 150 (4): 627,2016.
Bewtra Meenakshi, Fairchild Angelyn O, Gilroy Erin, Leiman David A, Kerner Caroline, Johnson F Reed, Lewis James D: Inflammatory Bowel Disease Patients' Willingness to Accept Medication Risk to Avoid Future Disease Relapse. The American journal of gastroenterology 110 (12): 1675-81,2015.
Patel U, Kerner, Lewis C, Agarwal A, Ford P: Outcomes in Bloodless Medicine Patients with Acute Gastrointestinal Bleeding American College of Gastroenterology Annual Meeting : 2014.
Kerner, C: Medical Therapy in the Preoperative and Postoperative Patient Medical Therapy of Ulcerative Colitis : 321-326,2014.
Kerner C, Osterman MT, Lewis JD: Safety Considerations in the Medical Therapy of Ulcerative Colitis Medical Therapy of Ulcerative Colitis : 297-311,2014.
Scott FI, Osterman MT, McConnell RA, Lorusso M, Aberra F, Kerner C, Lichtenstein GR, Lewis JD: Impact of JC virus antibody testing in patients with Crohn's disease with loss of response to infliximab: a Markov model Inflamm Bowel Dis 19 (12): 2625-2633,2013.